- Home
- DHR
as 05-30-2025 4:00pm EST
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
| Founded: | 1969 | Country: | United States |
| Employees: | N/A | City: | WASHINGTON |
| Market Cap: | 136.0B | IPO Year: | N/A |
| Target Price: | $264.88 | AVG Volume (30 days): | 3.9M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 18 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.16 | EPS Growth: | -12.59 |
| 52 Week Low/High: | $171.00 - $281.70 | Next Earning Date: | 07-22-2025 |
| Revenue: | $23,820,000,000 | Revenue Growth: | 0.35% |
| Revenue Growth (this year): | 3.76% | Revenue Growth (next year): | 6.54% |
Stock Insider Trading Activity of Danaher Corporation (DHR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| RALES STEVEN M | DHR | Chairman | May 12 '25 | Sell | $197.41 | 1,250,000 | $245,919,390.92 | 4,189,583 | |
| Riley Christopher Paul | DHR | Executive Vice President | Apr 30 '25 | Sell | $198.00 | 15,805 | $3,129,424.16 | 23,183 |
Latest Danaher Corporation News
DHR Breaking Stock News: Dive into DHR Ticker-Specific Updates for Smart Investing
Simply Wall St.
a day ago
Danaher (NYSE:DHR) Partners With AstraZeneca To Advance Precision Medicine Diagnostics
Zacks
a day ago
Danaher Partners With AstraZeneca to Support Precision Medicine
Medical Device Network
2 days ago
Danaher and AstraZeneca to develop diagnostic tools and tests
Insider Monkey
2 days ago
Danaher Corporation (DHR) Launches Partnership with AstraZeneca PLC (AZN) to Scale Next-Gen Precision Medicine Tests
MT Newswires
2 days ago
Danaher, AstraZeneca Collaborate on Precision Medicine
PR Newswire
2 days ago
Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine
StockStory
4 days ago
Research Tools & Consumables Stocks Q1 Recap: Benchmarking Mettler-Toledo (NYSE:MTD)
Zacks
5 days ago
CVS or DHR: Which Is the Better Value Stock Right Now?
Compare DHR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DHR Danaher Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.